tiprankstipranks
Trending News
More News >
Evogene (EVGN)
NASDAQ:EVGN
US Market

Evogene (EVGN) Income Statement

Compare
641 Followers

Evogene Income Statement

Last quarter (Q3 2025), Evogene's total revenue was $312.00K, a decrease of -82.07% from the same quarter last year. In Q3, Evogene's net income was $3.87M. See Evogene’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 8.51M$ 5.64M$ 1.68M$ 930.00K$ 1.04M
Gross Profit
$ 3.39M$ 1.40M$ -1.77M$ -2.07M$ -2.26M
Operating Expenses
$ 25.12M$ 27.79M$ 27.94M$ 29.42M$ 24.57M
Depreciation and Amortization
$ 2.50M$ 2.61M$ 2.58M$ 2.23M$ 2.73M
EBITDA
$ -15.38M$ -23.20M$ -26.93M$ -27.80M$ -23.18M
Operating Income
$ -21.73M$ -26.39M$ -29.71M$ -31.49M$ -26.84M
Other Income/Expenses
$ 3.69M$ 404.00K$ -39.00K$ 1.06M$ 661.00K
Pretax Income
$ -18.05M$ -25.99M$ -29.75M$ -30.43M$ -26.17M
Net Income
$ -16.48M$ -23.88M$ -26.64M$ -27.79M$ -23.37M
Per Share Metrics
Basic EPS
$ -2.89$ -5.23$ -6.46$ -0.68$ -0.64
Diluted EPS
$ -2.89$ -5.23$ -6.46$ -0.68$ -0.64
Weighted Average Shares Outstanding
5.70M 4.57M 4.12M 41.01M 36.55M
Weighted Average Shares Outstanding (Diluted)
5.70M 4.57M 4.12M 41.01M 36.55M
Currency in USD

Evogene Earnings and Revenue History